Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-02-08 @ 11:45 AM
Study NCT ID:
NCT03373435
Status:
COMPLETED
Last Update Posted:
2022-07-18
First Post:
2017-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Sponsor:
Eiger BioPharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Postbariatric Hypoglycemia | View |
Keywords: